Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
26
NMPA:26
Drug Approvals
Loxoprofen Sodium Cataplasms
- Product Name
- 洛索洛芬钠凝胶贴膏
- Approval Number
- 国药准字H20253228
- Approval Date
- Jan 24, 2025
NMPA
Rivastigmine Transdermal Patch
- Product Name
- 利斯的明透皮贴剂
- Approval Number
- 国药准字H20244948
- Approval Date
- Sep 19, 2024
NMPA
Esmolol Hydrochloride Injection
- Product Name
- 盐酸艾司洛尔注射液
- Approval Number
- 国药准字H20093381
- Approval Date
- Mar 22, 2024
NMPA
Esmolol Hydrochloride Injection
- Product Name
- 盐酸艾司洛尔注射液
- Approval Number
- 国药准字H20093380
- Approval Date
- Mar 22, 2024
NMPA
Sugammadex Sodium Injection
- Product Name
- 舒更葡糖钠注射液
- Approval Number
- 国药准字H20234504
- Approval Date
- Nov 21, 2023
NMPA
Sodium Ozagrel Injection
- Product Name
- 奥扎格雷钠注射液
- Approval Number
- 国药准字H20073978
- Approval Date
- Mar 23, 2023
NMPA
Pioglitazone Hydrochloride Dispersible Tablets
- Product Name
- 盐酸吡格列酮分散片
- Approval Number
- 国药准字H20080703
- Approval Date
- Feb 27, 2023
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found